Strategic Evidence & Value Communication Symposium
Join us on Wednesday, April 21, 2021, from12:00 PM – 2:00 PM EDT for Certara’s…
CertaraMarch 26, 2021
Prelude Therapeutics reduces their quality control (QC) process for regulatory submissions from hours to minutes with Certara’s GlobalSubmit eCTD Software
In 2019, Prelude Therapeutics, a small cancer drug discovery company, implemented Certara’s GlobalSubmit submissions management…
CertaraMarch 2, 2021
Getting Gene Therapies to Patients
This blog discusses the challenges that drug developers face in getting patients access to cell…
CertaraFebruary 16, 2021
Early Value Assessment in Gene Therapy Clinical Trial Design
A global biotechnology company engineering precision genetic medicine for rare diseases was in need of…
CertaraFebruary 12, 2021
Getting Real with RWE
By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…
CertaraNovember 20, 2020
Galderma Achieves FDA Approval of AKLIEF® (trifarotene)
In October 2019, Galderma announced that the U.S. FDA approved AKLIEF® (trifarotene) Cream, 0.005% for the…
CertaraNovember 9, 2020
